98 related articles for article (PubMed ID: 7508336)
21. Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells.
Bereta M; Bereta J; Georgoff I; Coffman FD; Cohen S; Cohen MC
Exp Cell Res; 1994 Jun; 212(2):230-42. PubMed ID: 7514535
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice.
Ribeiro RA; Freitas HC; Campos MC; Santos CC; Figueiredo FC; Brito GA; Cunha FQ
J Urol; 2002 May; 167(5):2229-34. PubMed ID: 11956484
[TBL] [Abstract][Full Text] [Related]
23. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis.
Wang B; Wei D; Crum VE; Richardson EL; Xiong HH; Luo Y; Huang S; Abbruzzese JL; Xie K
Oncogene; 2003 Mar; 22(12):1771-82. PubMed ID: 12660813
[TBL] [Abstract][Full Text] [Related]
24. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
25. Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages.
Bogdan C; Vodovotz Y; Paik J; Xie QW; Nathan C
J Immunol; 1993 Jul; 151(1):301-9. PubMed ID: 7686937
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
27. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.
Deng W; Thiel B; Tannenbaum CS; Hamilton TA; Stuehr DJ
J Immunol; 1993 Jul; 151(1):322-9. PubMed ID: 7686939
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements.
Price JE; Aukerman SL; Fidler IJ
Cancer Res; 1986 Oct; 46(10):5172-8. PubMed ID: 3756871
[TBL] [Abstract][Full Text] [Related]
29. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells.
Xie K; Huang S; Dong Z; Juang SH; Gutman M; Xie QW; Nathan C; Fidler IJ
J Exp Med; 1995 Apr; 181(4):1333-43. PubMed ID: 7535333
[TBL] [Abstract][Full Text] [Related]
30. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell.
Fidler IJ; Talmadge JE
Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin.
Fidler IJ; Gruys E; Cifone MA; Barnes Z; Bucana C
J Natl Cancer Inst; 1981 Oct; 67(4):947-56. PubMed ID: 6944560
[TBL] [Abstract][Full Text] [Related]
32. Influence of organ microenvironment on pigmentation of a metastatic murine melanoma.
Price JE; Tarin D; Fidler IJ
Cancer Res; 1988 Apr; 48(8):2258-64. PubMed ID: 2832058
[TBL] [Abstract][Full Text] [Related]
33. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
Staroselsky AH; Pathak S; Chernajovsky Y; Tucker SL; Fidler IJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6292-8. PubMed ID: 1834329
[TBL] [Abstract][Full Text] [Related]
34. Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases.
Aukerman SL; Price JE; Fidler IJ
J Natl Cancer Inst; 1986 Oct; 77(4):915-24. PubMed ID: 3463821
[TBL] [Abstract][Full Text] [Related]
35. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene.
Xie K; Huang S; Dong Z; Juang SH; Wang Y; Fidler IJ
J Natl Cancer Inst; 1997 Mar; 89(6):421-7. PubMed ID: 9091643
[TBL] [Abstract][Full Text] [Related]
36. Activation of nitric oxide synthase gene for inhibition of cancer metastasis.
Xie K; Dong Z; Fidler IJ
J Leukoc Biol; 1996 Jun; 59(6):797-803. PubMed ID: 8691063
[TBL] [Abstract][Full Text] [Related]
37. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.
Xie K; Fidler IJ
Cancer Metastasis Rev; 1998 Mar; 17(1):55-75. PubMed ID: 9544423
[TBL] [Abstract][Full Text] [Related]
38. Changes in clonal composition during in vivo growth of mixed subpopulations derived from the murine K-1735 melanoma.
Staroselsky A; Pathak S; Fidler IJ
Anticancer Res; 1990; 10(2A):291-6. PubMed ID: 2346303
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide induces Ca(2+)-independent nitric oxide synthase activity in rat gastric mucosal cells.
Brown JF; Tepperman BL; Hanson PJ; Whittle BJ
Eur J Pharmacol; 1994 Nov; 292(1):111-4. PubMed ID: 7532587
[TBL] [Abstract][Full Text] [Related]
40. Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells.
Wei Q; Cheng L; Xie K; Bucana CD; Dong Z
J Invest Dermatol; 1997 Jan; 108(1):3-6. PubMed ID: 8980277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
